Long term treatment free remission can be achieved in most chronic myeloid leukaemia patients who show a deep molecular response with second-line nilotinib therapy, researchers from South Australia have shown in a multinational trial. The findings come from a trial led by researchers from South Australian Health and Medical Research Institute, who studied 163 patients ...
CML patients can achieve treatment free remission after switching to nilotinib
By Michael Woodhead
21 Feb 2018